XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Deficit and Loss Per Share
6 Months Ended
Jun. 30, 2024
Stockholders' Deficit and Loss Per Share [Line Items]  
Equity [Text Block]


Note 10 – Stockholders’ Deficit and Loss Per Share

 

The following table presents the calculation of loss per share for the three and six months ended June 30, 2024 and 2023:

 

 

In thousands, except per share data

 

Three months ended June 30

 

Six months ended June 30

2024

 

2023

 

2024

 

2023

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 Net loss, as reported

$

   (858)

 

$

   (875)

 

$

  (2,127)

 

$

  (1,733)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 Weighted average shares outstanding – basic and diluted

 

13,496

 

 

13,491

 

 

13,496

 

 

13,469

Loss per share – basic and diluted

$

   (0.06)

 

$

   (0.06)

 

$

   (0.16)

 

$

   (0.13)

 

Basic loss per common share is computed by dividing net loss attributable to common shares by the weighted average number of common shares outstanding for the period. Diluted loss per common share is computed by dividing net loss attributable to common shares, by the weighted average number of common shares outstanding, adjusted for shares that would be assumed outstanding after warrants and stock options vested under the treasury stock method.

 

As of June 30, 2024 and 2023, the Company excluded the effects of the outstanding stock options to purchase 280,000 shares in the calculation of diluted loss per share since their inclusion would have been anti-dilutive. The Company had other warrants to purchase 1.1 million and 1.6 million shares of Common Stock outstanding as of June 30, 2024 and 2023, respectively, which were excluded from the calculation of diluted loss per share because their exercise price was greater than the average stock price for the period and their inclusion would have been anti-dilutive.

 

A summary of the status of the Company’s stock options as of June 30, 2024 and the changes during the six months then ended is presented below:

 

 

Number of
Options

   

Weighted Average
Exercise Price

 

Weighted average
remaining contractual
life (in years)

    

Average intrinsic value

Outstanding at December 31, 2023

280,000

 

$

0.40

 

2.3

 

$

0.19

Granted

-

-

Expired

-

 

-

 

 

$

0.19

Outstanding at June 30, 2024

280,000

 

$

0.40

1.8

$

0.19

Exercisable at the end of the period

280,000

 

$

0.40

 

1.8

 

$

0.19

 

There was no equity based compensation for the three or six months ended June 30, 2024.  Equity based compensation was $38,000 for the six months ended June 30, 2023. There was no equity based compensation for the three months ended June 30, 2023. There is no more unrecognized equity based compensation cost related to unvested stock options as of June 30, 2024.